tiprankstipranks
Advertisement

HFXI - ETF AI Analysis

Compare

Top Page

HFXI

IQ 50 Percent Hedged FTSE International ETF (HFXI)

Rating:59Neutral
Price Target:
HFXI, the IQ 50 Percent Hedged FTSE International ETF, has a solid but not top-tier rating, reflecting a mix of strong global blue-chip holdings and some areas of caution. High-quality names like Novartis, HSBC, and AstraZeneca support the fund’s quality through strong financial performance, positive earnings outlooks, and generally reasonable valuations, while companies such as Roche and Shell introduce some risk due to valuation concerns, potential overbought or weak technical signals, and growth challenges. The main risk factor is that several key holdings share issues like high valuations or softer technical trends, which can limit upside even though the overall portfolio remains diversified across sectors and regions.
Positive Factors
Strong Year-to-Date Performance
The ETF has shown strong gains so far this year, suggesting its strategy has worked well in the recent market environment.
Leading Global Companies in Top Holdings
Several of the largest positions, including major technology and financial firms, have delivered strong performance and help drive the fund’s returns.
Broad International Diversification
The fund spreads its investments across many countries and sectors, which helps reduce the impact of problems in any single market or industry.
Negative Factors
Mixed Performance Among Top Holdings
While many key stocks are performing well, a few notable names have been weak, which can drag on overall results if the trend continues.
Heavy Exposure to Japan and the UK
A large portion of the portfolio is concentrated in Japan and the UK, increasing the fund’s sensitivity to economic or political issues in those markets.
Currency Hedging Complexity
Because the ETF uses a partial currency hedge, its returns can behave differently from fully hedged or unhedged international funds, which may be harder for some investors to understand.

HFXI vs. SPDR S&P 500 ETF (SPY)

HFXI Summary

HFXI is the IQ 50 Percent Hedged FTSE International ETF, which follows the FTSE Developed ex North America 50% Hedged to USD Index. It invests in many large and mid-sized companies across developed countries like Japan, the UK, and South Korea. Well-known holdings include Samsung Electronics, Nestlé, and AstraZeneca. Investors might consider HFXI for broad international diversification, while its 50% currency hedge aims to reduce the impact of foreign exchange swings on returns. A key risk is that the fund still moves with global stock markets, so its value can go up and down significantly over time.
How much will it cost me?The IQ 50 Percent Hedged FTSE International ETF (HFXI) has an expense ratio of 0.20%, which means you’ll pay $2 per year for every $1,000 invested. This is lower than average because it is passively managed, tracking an index rather than relying on active stock picking.
What would affect this ETF?HFXI could benefit from growth in developed international markets, especially if sectors like financials and technology perform well, as they are heavily weighted in the ETF. However, potential risks include economic slowdowns in Europe or Asia, regulatory changes affecting top holdings like ASML and Nestlé, and adverse currency movements despite partial hedging. Global interest rate changes and geopolitical tensions could also impact the ETF's performance.

HFXI Top 10 Holdings

HFXI leans heavily on global blue chips, with Asian tech and European health care setting the tone. Samsung and SK hynix are key drivers when semiconductor sentiment is rising, though their recent moves have been mixed, adding some bumpiness. ASML has been a powerful engine over the year but is currently losing a bit of steam. On the defensive side, Roche and Novartis are steady anchors, while Nestlé and AstraZeneca have been lagging, slightly dragging on returns. Overall, the fund offers a diversified, developed-markets mix outside North America.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Samsung Electronics3.20%$66.49M₩10.00T>230.73%
ASML Holding NV2.52%$52.37M€572.60B143.26%
76
Outperform
SK hynix Inc.2.13%$44.25M₩10.00T>431.84%
HSBC Holdings1.32%$27.46M£262.77B60.76%
80
Outperform
Roche Holding AG1.26%$26.21M$361.51B51.16%
73
Outperform
Novartis AG1.10%$22.82MCHF230.61B32.06%
80
Outperform
Nestlé SA0.95%$19.81MCHF208.89B10.64%
71
Outperform
Shell (UK)0.94%$19.63M£181.34B24.71%
73
Outperform
Mitsubishi UFJ Financial Group0.92%$19.20M¥39.85T52.16%
76
Outperform
AstraZeneca0.91%$18.84M$249.26B8.64%
80
Outperform

HFXI Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
37.52
Positive
100DMA
36.51
Positive
200DMA
34.71
Positive
Market Momentum
MACD
0.27
Negative
RSI
62.54
Neutral
STOCH
91.61
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For HFXI, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 37.49, equal to the 50-day MA of 37.52, and equal to the 200-day MA of 34.71, indicating a bullish trend. The MACD of 0.27 indicates Negative momentum. The RSI at 62.54 is Neutral, neither overbought nor oversold. The STOCH value of 91.61 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HFXI.

HFXI Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$2.11B0.20%
59
Neutral
$9.36B0.35%
65
Neutral
$6.59B0.07%
66
Neutral
$5.50B0.20%
61
Neutral
$2.24B0.58%
66
Neutral
$1.50B0.40%
65
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HFXI
IQ 50 Percent Hedged FTSE International ETF
38.60
9.21
31.34%
DBEF
Xtrackers MSCI EAFE Hedged Equity ETF
BBIN
JPMorgan BetaBuilders International Equity ETF
EFAV
iShares MSCI EAFE Min Vol Factor ETF
IHDG
WisdomTree International Hedged Quality Dividend Growth Fund
DDWM
WisdomTree Dynamic Currency Hedged International Equity Fund
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement